基本信息
views: 110
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Julien is recognized as one of the most influential scientists in the field of amyotrophic lateral sclerosis (ALS) and neurodegenerative disease.
He was awarded the prestigious Sheila Essey Award for research on ALS from the American Academy of Neurology, the prix Léo-Pariseau and the Jonas Salk Award of March of Dimes. He is member of the Canadian Academy of Health Sciences and of the Royal Society of Canada. He is a member of the Robert Packard Center for ALS Research at Johns Hopkins University. He has been a member of advisory board of CIHR Institute of Genetics and on the Gairdner medical review panel. He has been the organizer since 2005 of the Annual Symposium on ALS of the Fondation André-Delambre. He has made important contributions to the current understanding of ALS pathogenesis caused by TDP-43 proteinopathy and mutations in superoxide dismutase (SOD1). He was the first to report that disorganization of neurofilaments can cause motor neuron degeneration in transgenic mice and to develop immunization approaches for ALS treatment. He discovered a new therapeutic target for ALS which involves a key protein of the innate immune response. These findings might form the basis for the development of new experimental therapeutics for ALS and related disorders.
He was awarded the prestigious Sheila Essey Award for research on ALS from the American Academy of Neurology, the prix Léo-Pariseau and the Jonas Salk Award of March of Dimes. He is member of the Canadian Academy of Health Sciences and of the Royal Society of Canada. He is a member of the Robert Packard Center for ALS Research at Johns Hopkins University. He has been a member of advisory board of CIHR Institute of Genetics and on the Gairdner medical review panel. He has been the organizer since 2005 of the Annual Symposium on ALS of the Fondation André-Delambre. He has made important contributions to the current understanding of ALS pathogenesis caused by TDP-43 proteinopathy and mutations in superoxide dismutase (SOD1). He was the first to report that disorganization of neurofilaments can cause motor neuron degeneration in transgenic mice and to develop immunization approaches for ALS treatment. He discovered a new therapeutic target for ALS which involves a key protein of the innate immune response. These findings might form the basis for the development of new experimental therapeutics for ALS and related disorders.
Research Interests
Papers共 308 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Biological Chemistryno. 5 (2024): 107207-107207
Biomedicinesno. 5 (2024): 1017
crossref(2023)
crossref(2023)
Brain : a journal of neurologyno. 9 (2023): 3624-3633
The Journal of neuroscience : the official journal of the Society for Neuroscienceno. 22 (2023): 4174-4189
Mari Carmen Pelaez, Antoine Desmeules, Pauline A. Gelon,Bastien Glasson,Laetitia Marcadet, Alicia Rodgers,Daniel Phaneuf,Silvia Pozzi,Paul A. Dutchak,Jean-Pierre Julien,Chantelle F. Sephton
Acta neuropathologica communicationsno. 1 (2023): 1-21
Fabiola De Marchi, Toni Franjkic,Paride Schito,Tommaso Russo,Jerneja Nimac,Anna A Chami, Angelica Mele,Lea Vidatic,Jasna Kriz,Jean-Pierre Julien,Gordana Apic,Robert B Russell,
Biomedicinesno. 6 (2023): 1599-1599
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn